Ratings by Rodman & Renshaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 6/9/2026 | Michael King Jr. | Kyntra Bio | KYNB | New Coverage | Buy (N/A) |
30.00 (N/A) |
6.63 (7.13) |
7.54% | Details |
| 6/3/2026 | Seema Sheoran | Neurogene | NGNE | New Coverage | Buy (N/A) |
70.00 (N/A) |
26.14 (29.10) |
11.32% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 76 more... | |||||||||


